의약품 물류 시장 규모, 점유율, 성장 및 산업 분석 : 유형별, 용도별, 지역별 인사이트 및 예측(2026-2034년)

Growth Factors of pharmaceutical logistics Market

The global pharmaceutical logistics market is witnessing steady expansion driven by rising demand for temperature-sensitive medicines and advanced supply chain technologies. The market was valued at USD 80.56 billion in 2025 and is projected to grow from USD 85.15 billion in 2026 to USD 156.39 billion by 2034, exhibiting a CAGR of 7.90% during the forecast period (2026-2034). Europe dominated the global market with a 65.34% share in 2025, supported by strong regulatory compliance and advanced healthcare infrastructure.

Pharmaceutical logistics involves the planning, storage, transportation, and distribution of medicines, vaccines, biologics, and medical supplies while maintaining strict quality and temperature controls. With the growing complexity of pharmaceutical products, efficient logistics systems have become critical to ensure safe and timely delivery worldwide.

Market Dynamics

Market Drivers

Rising Demand for Biologics and Specialty Drugs

The increasing production of biologics, monoclonal antibodies, gene therapies, and vaccines is significantly driving demand for advanced pharmaceutical logistics. These products require specialized cold chain systems, temperature-controlled warehouses, and real-time monitoring solutions. As global healthcare demand increases, logistics providers are expanding cold storage capabilities and investing in digital tracking technologies.

Technological Advancements

Innovations such as IoT-enabled sensors, AI-based route optimization, blockchain traceability, and automated warehousing are transforming pharmaceutical logistics. These technologies improve visibility, reduce spoilage risks, and ensure compliance with Good Distribution Practices (GDP). Digital integration across supply chains enhances efficiency and minimizes operational delays.

Market Restraints

High Infrastructure and Compliance Costs

Cold chain infrastructure requires substantial capital investment in refrigerated vehicles, monitoring systems, and specialized storage facilities. Compliance with international regulatory standards further increases operational complexity. Smaller logistics providers often face barriers due to these high setup and maintenance costs.

Market Opportunities

Growth of E-Commerce and Direct-to-Patient (DTP) Delivery

The rise of online pharmacies and telemedicine has created strong demand for last-mile pharmaceutical delivery. Patients increasingly expect fast and secure home delivery of medicines. Logistics providers offering temperature-controlled packaging, real-time tracking, and contactless delivery are gaining competitive advantage in this rapidly expanding segment.

Pharmaceutical Logistics Market Trends

Outsourcing to Third-Party Logistics (3PL) Providers

Pharmaceutical companies are increasingly outsourcing logistics to specialized 3PL providers to focus on core R&D activities. Outsourcing reduces capital expenditure and enhances scalability in emerging markets. Advanced tracking systems and AI-driven supply chain management tools further strengthen outsourced logistics operations.

Segmentation Analysis

By Transportation Mode

• Roadways dominated the market with 62.74% share in 2026, driven by flexibility, cost-effectiveness, and last-mile delivery capabilities.
• Airways are expected to grow at the fastest rate due to the urgent delivery needs of high-value and temperature-sensitive drugs.

By Service Type

• Transportation services accounted for 42.53% of the global market share, supported by rising demand for secure and rapid medicine delivery.
• Inventory management holds the second-largest share due to the need for real-time stock monitoring.

By Logistics Type

• Non-cold chain logistics led the market with 55.51% share in 2026, driven by high volumes of non-temperature-sensitive pharmaceuticals.
• Cold chain logistics is the fastest-growing segment due to increasing biologics and vaccine demand.

By Product Type

• Finished pharmaceutical goods are projected to dominate with 52.13% share in 2026, supported by rising global healthcare access.
• Biopharmaceuticals are growing rapidly due to complex treatment demand.

Regional Outlook

Europe

Europe accounted for USD 52.64 billion in 2025, maintaining its leading position due to strict regulatory frameworks and strong cold chain infrastructure. Countries such as Germany and Switzerland are major contributors to regional growth.

North America

North America held the second-largest share, valued at USD 14.81 billion in 2025. Growth is driven by high biologics demand and advanced healthcare systems.

Asia Pacific

Asia Pacific reached USD 10.77 billion in 2025, supported by expanding pharmaceutical manufacturing in China and India and rising healthcare investments.

Rest of the World

The region generated USD 2.34 billion in 2025 and is expected to grow steadily due to improving healthcare infrastructure.

Competitive Landscape

The market is highly competitive with major players including DHL, UPS Healthcare, FedEx Supply Chain, Kuehne + Nagel, CEVA Logistics, DB Schenker, DSV, GEODIS, and C.H. Robinson. Companies focus on mergers, acquisitions, advanced cold chain solutions, and digital supply chain integration to strengthen their global presence.

Conclusion

The pharmaceutical logistics market is positioned for consistent growth from USD 80.56 billion in 2025 to USD 156.39 billion by 2034, driven by rising biologics demand, expanding cold chain infrastructure, and digital transformation in supply chain management. While high infrastructure costs and regulatory complexities pose challenges, opportunities in e-commerce, direct-to-patient delivery, and emerging markets offer significant long-term potential. As pharmaceutical innovation accelerates globally, advanced logistics solutions will remain essential to ensure safe, efficient, and compliant drug distribution worldwide.

Segmentation By Transportation Mode

• Airways
• Railways
• Roadways
• Waterways

By Service Type

• Warehouse Services
• Transportation
• Inventory management
• Administration & Supplies

By Logistics Type

• Cold Chain Logistics
• Non-Cold Chain Logistics

By Product Type

• Biological
• Biopharmaceutical
• Raw Pharmaceutical Materials
• Finished Pharmaceutical Goods
• Medical Supplies
• Specialty Pharmaceutical

By Region

• North America (By Transportation Mode, By Service Type, By Logistics Type, and By Product Type)
  • U.S. (By Product Type and By Logistics Type)
  • Canada (By Product Type and By Logistics Type)
  • Mexico (By Product Type and By Logistics Type)
• Europe (By Transportation Mode, By Service Type, By Logistics Type, and By Product Type)
  • Germany (By Product Type and By Logistics Type)
  • France (By Product Type and By Logistics Type)
  • Poland (By Product Type and By Logistics Type)
  • Rest of Europe (By Product Type and By Logistics Type)
• Asia Pacific (By Transportation Mode, By Service Type, By Logistics Type, and By Product Type)
  • China (By Product Type and By Logistics Type)
  • Japan (By Product Type and By Logistics Type)
  • South Korea (By Product Type and By Logistics Type)
  • Rest of Asia Pacific (By Product Type and By Logistics Type)
• Rest of World (By Transportation Mode, By Service Type, By Logistics Type, and By Product Type)

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Key Industry Developments - Mergers, Acquisitions & Partnerships
• 4.2. Latest Technological Advancements
• 4.3. Porters Five Forces Analysis
• 4.4. Regulatory Landscape
• 4.5. Impact of Tariff on Global Pharmaceutical Logsistics Market

5. Global Pharmaceutical Logsistics Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Key Findings / Definition
• 5.2. Market Analysis, Insights and Forecast - Transportation Mode
  • 5.2.1. Airways
  • 5.2.2. Railways
  • 5.2.3. Roadways
  • 5.2.4. Waterways
• 5.3. Market Analysis, Insights and Forecast - Service Type
  • 5.3.1. Warehouse Services
  • 5.3.2. Transportation
  • 5.3.3. Inventory management
  • 5.3.4. Administration & Supplies
• 5.4. Market Analysis, Insights and Forecast - By Logistics Type
  • 5.4.1. Cold Chain Logistics
  • 5.4.2. Non-Cold Chain Logistics
• 5.5. Market Analysis, Insights and Forecast - By Product Type
  • 5.5.1. Biological
  • 5.5.2. Biopharmaceutical
  • 5.5.3. Raw Pharmaceutical Materials
  • 5.5.4. Finished Pharmaceutical Goods
  • 5.5.5. Medical Supplies
  • 5.5.6. Specialty Pharmaceutical
• 5.6. Market Analysis, Insights and Forecast - By Region
  • 5.6.1. North America
  • 5.6.2. Europe
  • 5.6.3. Asia Pacific
  • 5.6.4. Rest of the World

6. North America Pharmaceutical Logsistics Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights and Forecast - Transportation Mode
  • 6.1.1. Airways
  • 6.1.2. Railways
  • 6.1.3. Roadways
  • 6.1.4. Waterways
• 6.2. Market Analysis, Insights and Forecast - Service Type
  • 6.2.1. Warehouse Services
  • 6.2.2. Transportation
  • 6.2.3. Inventory management
  • 6.2.4. Administration & Supplies
• 6.3. Market Analysis, Insights and Forecast - By Logistics Type
  • 6.3.1. Cold Chain Logistics
  • 6.3.2. Non-Cold Chain Logistics
• 6.4. Market Analysis, Insights and Forecast - By Product Type
  • 6.4.1. Biological
  • 6.4.2. Biopharmaceutical
  • 6.4.3. Raw Pharmaceutical Materials
  • 6.4.4. Finished Pharmaceutical Goods
  • 6.4.5. Medical Supplies
  • 6.4.6. Specialty Pharmaceutical
• 6.5. Market Analysis, Insights and Forecast - By Country
  • 6.5.1. U.S.
    • 6.5.1.1. Market Analysis, Insights and Forecast - By Logistics Type
    • 6.5.1.2. Market Analysis, Insights and Forecast - By Product Type
  • 6.5.2. Canada
    • 6.5.2.1. Market Analysis, Insights and Forecast - By Logistics Type
    • 6.5.2.2. Market Analysis, Insights and Forecast - By Product Type
  • 6.5.3. Mexico
    • 6.5.3.1. Market Analysis, Insights and Forecast - By Logistics Type
    • 6.5.3.2. Market Analysis, Insights and Forecast - By Product Type

7. Europe Pharmaceutical Logsistics Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights and Forecast - Transportation Mode
  • 7.1.1. Airways
  • 7.1.2. Railways
  • 7.1.3. Roadways
  • 7.1.4. Waterways
• 7.2. Market Analysis, Insights and Forecast - Service Type
  • 7.2.1. Warehouse Services
  • 7.2.2. Transportation
  • 7.2.3. Inventory management
  • 7.2.4. Administration & Supplies
• 7.3. Market Analysis, Insights and Forecast - By Logistics Type
  • 7.3.1. Cold Chain Logistics
  • 7.3.2. Non-Cold Chain Logistics
• 7.4. Market Analysis, Insights and Forecast - By Product Type
  • 7.4.1. Biological
  • 7.4.2. Biopharmaceutical
  • 7.4.3. Raw Pharmaceutical Materials
  • 7.4.4. Finished Pharmaceutical Goods
  • 7.4.5. Medical Supplies
  • 7.4.6. Specialty Pharmaceutical
• 7.5. Market Analysis, Insights and Forecast - By Country
  • 7.5.1. Germany
    • 7.5.1.1. Market Analysis, Insights and Forecast - By Logistics Type
    • 7.5.1.2. Market Analysis, Insights and Forecast - By Product Type
  • 7.5.2. Switzerland
    • 7.5.2.1. Market Analysis, Insights and Forecast - By Logistics Type
    • 7.5.2.2. Market Analysis, Insights and Forecast - By Product Type
  • 7.5.3. France
    • 7.5.3.1. Market Analysis, Insights and Forecast - By Logistics Type
    • 7.5.3.2. Market Analysis, Insights and Forecast - By Product Type
  • 7.5.4. Rest of Europe
    • 7.5.4.1. Market Analysis, Insights and Forecast - By Logistics Type
    • 7.5.4.2. Market Analysis, Insights and Forecast - By Product Type

8. Asia Pacific Pharmaceutical Logsistics Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights and Forecast - Transportation Mode
  • 8.1.1. Airways
  • 8.1.2. Railways
  • 8.1.3. Roadways
  • 8.1.4. Waterways
• 8.2. Market Analysis, Insights and Forecast - Service Type
  • 8.2.1. Warehouse Services
  • 8.2.2. Transportation
  • 8.2.3. Inventory management
  • 8.2.4. Administration & Supplies
• 8.3. Market Analysis, Insights and Forecast - By Logistics Type
  • 8.3.1. Cold Chain Logistics
  • 8.3.2. Non-Cold Chain Logistics
• 8.4. Market Analysis, Insights and Forecast - By Product Type
  • 8.4.1. Biological
  • 8.4.2. Biopharmaceutical
  • 8.4.3. Raw Pharmaceutical Materials
  • 8.4.4. Finished Pharmaceutical Goods
  • 8.4.5. Medical Supplies
  • 8.4.6. Specialty Pharmaceutical
• 8.5. Market Analysis, Insights and Forecast - By Country
  • 8.5.1. China
    • 8.5.1.1. Market Analysis, Insights and Forecast - By Logistics Type
    • 8.5.1.2. Market Analysis, Insights and Forecast - By Product Type
  • 8.5.2. Japan
    • 8.5.2.1. Market Analysis, Insights and Forecast - By Logistics Type
    • 8.5.2.2. Market Analysis, Insights and Forecast - By Product Type
  • 8.5.3. South Korea
    • 8.5.3.1. Market Analysis, Insights and Forecast - By Logistics Type
    • 8.5.3.2. Market Analysis, Insights and Forecast - By Product Type
  • 8.5.4. Rest of Asia Pacific
    • 8.5.4.1. Market Analysis, Insights and Forecast - By Logistics Type
    • 8.5.4.2. Market Analysis, Insights and Forecast - By Product Type

9. Rest of the World Pharmaceutical Logsistics Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights and Forecast - Transportation Mode
  • 9.1.1. Airways
  • 9.1.2. Railways
  • 9.1.3. Roadways
  • 9.1.4. Waterways
• 9.2. Market Analysis, Insights and Forecast - Service Type
  • 9.2.1. Warehouse Services
  • 9.2.2. Transportation
  • 9.2.3. Inventory management
  • 9.2.4. Administration & Supplies
• 9.3. Market Analysis, Insights and Forecast - By Logistics Type
  • 9.3.1. Cold Chain Logistics
  • 9.3.2. Non-Cold Chain Logistics
• 9.4. Market Analysis, Insights and Forecast - By Product Type
  • 9.4.1. Biological
  • 9.4.2. Biopharmaceutical
  • 9.4.3. Raw Pharmaceutical Materials
  • 9.4.4. Finished Pharmaceutical Goods
  • 9.4.5. Medical Supplies
  • 9.4.6. Specialty Pharmaceutical

10. Competitive Analysis

• 10.1. Key Industry Developments
• 10.2. Global Market Rank Analysis (2025)
• 10.3. Competitive Dashboard
• 10.4. Comparative Analysis - Major Players
• 10.5. Company Profiles
  • 10.5.1. Apollo Couriers (India)
    • 10.5.1.1. Overview
    • 10.5.1.2. Products & services
    • 10.5.1.3. SWOT Analysis
    • 10.5.1.4. Recent Developments
    • 10.5.1.5. Strategies
    • 10.5.1.6. Financials (Based on Availability)
  • 10.5.2. DHL (Germany)
    • 10.5.2.1. Overview
    • 10.5.2.2. Products & services
    • 10.5.2.3. SWOT Analysis
    • 10.5.2.4. Recent Developments
    • 10.5.2.5. Strategies
    • 10.5.2.6. Financials (Based on Availability)
  • 10.5.3. FarEye (India)
    • 10.5.3.1. Overview
    • 10.5.3.2. Products & services
    • 10.5.3.3. SWOT Analysis
    • 10.5.3.4. Recent Developments
    • 10.5.3.5. Strategies
    • 10.5.3.6. Financials (Based on Availability)
  • 10.5.4. Allcargo Logistics (India)
    • 10.5.4.1. Overview
    • 10.5.4.2. Products & services
    • 10.5.4.3. SWOT Analysis
    • 10.5.4.4. Recent Developments
    • 10.5.4.5. Strategies
    • 10.5.4.6. Financials (Based on Availability)
  • 10.5.5. Jones Elite Logistics (United States)
    • 10.5.5.1. Overview
    • 10.5.5.2. Products & services
    • 10.5.5.3. SWOT Analysis
    • 10.5.5.4. Recent Developments
    • 10.5.5.5. Strategies
    • 10.5.5.6. Financials (Based on Availability)
  • 10.5.6. Buske Logistics (United States)
    • 10.5.6.1. Overview
    • 10.5.6.2. Products & services
    • 10.5.6.3. SWOT Analysis
    • 10.5.6.4. Recent Developments
    • 10.5.6.5. Strategies
    • 10.5.6.6. Financials (Based on Availability)
  • 10.5.7. Logisber (Spain)
    • 10.5.7.1. Overview
    • 10.5.7.2. Products & services
    • 10.5.7.3. SWOT Analysis
    • 10.5.7.4. Recent Developments
    • 10.5.7.5. Strategies
    • 10.5.7.6. Financials (Based on Availability)
  • 10.5.8. DHL Supply Chain (Germany)
    • 10.5.8.1. Overview
    • 10.5.8.2. Products & services
    • 10.5.8.3. SWOT Analysis
    • 10.5.8.4. Recent Developments
    • 10.5.8.5. Strategies
    • 10.5.8.6. Financials (Based on Availability)
  • 10.5.9. Kuehne + Nagel (Switzerland)
    • 10.5.9.1. Overview
    • 10.5.9.2. Products & services
    • 10.5.9.3. SWOT Analysis
    • 10.5.9.4. Recent Developments
    • 10.5.9.5. Strategies
    • 10.5.9.6. Financials (Based on Availability)
  • 10.5.10. UPS Healthcare (United States)
    • 10.5.10.1. Overview
    • 10.5.10.2. Products & services
    • 10.5.10.3. SWOT Analysis
    • 10.5.10.4. Recent Developments
    • 10.5.10.5. Strategies
    • 10.5.10.6. Financials (Based on Availability)
  • 10.5.11. XPO Logistics (United States)
    • 10.5.11.1. Overview
    • 10.5.11.2. Products & services
    • 10.5.11.3. SWOT Analysis
    • 10.5.11.4. Recent Developments
    • 10.5.11.5. Strategies
    • 10.5.11.6. Financials (Based on Availability)
  • 10.5.12. C.H. Robinson (United States)
    • 10.5.12.1. Overview
    • 10.5.12.2. Products & services
    • 10.5.12.3. SWOT Analysis
    • 10.5.12.4. Recent Developments
    • 10.5.12.5. Strategies
    • 10.5.12.6. Financials (Based on Availability)
  • 10.5.13. DB Schenker (Germany)
    • 10.5.13.1. Overview
    • 10.5.13.2. Products & services
    • 10.5.13.3. SWOT Analysis
    • 10.5.13.4. Recent Developments
    • 10.5.13.5. Strategies
    • 10.5.13.6. Financials (Based on Availability)
  • 10.5.14. Kerry Logistics (Hong Kong)
    • 10.5.14.1. Overview
    • 10.5.14.2. Products & services
    • 10.5.14.3. SWOT Analysis
    • 10.5.14.4. Recent Developments
    • 10.5.14.5. Strategies
    • 10.5.14.6. Financials (Based on Availability)
  • 10.5.15. GEODIS (France)
    • 10.5.15.1. Overview
    • 10.5.15.2. Products & services
    • 10.5.15.3. SWOT Analysis
    • 10.5.15.4. Recent Developments
    • 10.5.15.5. Strategies
    • 10.5.15.6. Financials (Based on Availability)
  • 10.5.16. Kintetsu World Express (Japan)
    • 10.5.16.1. Overview
    • 10.5.16.2. Products & services
    • 10.5.16.3. SWOT Analysis
    • 10.5.16.4. Recent Developments
    • 10.5.16.5. Strategies
    • 10.5.16.6. Financials (Based on Availability)
  • 10.5.17. Triton International (United States)
    • 10.5.17.1. Overview
    • 10.5.17.2. Products & services
    • 10.5.17.3. SWOT Analysis
    • 10.5.17.4. Recent Developments
    • 10.5.17.5. Strategies
    • 10.5.17.6. Financials (Based on Availability)
  • 10.5.18. CEVA Logistics (Switzerland)
    • 10.5.18.1. Overview
    • 10.5.18.2. Products & services
    • 10.5.18.3. SWOT Analysis
    • 10.5.18.4. Recent Developments
    • 10.5.18.5. Strategies
    • 10.5.18.6. Financials (Based on Availability)
  • 10.5.19. Agility Logistics (Kuwait)
    • 10.5.19.1. Overview
    • 10.5.19.2. Products & services
    • 10.5.19.3. SWOT Analysis
    • 10.5.19.4. Recent Developments
    • 10.5.19.5. Strategies
    • 10.5.19.6. Financials (Based on Availability)
  • 10.5.20. DSV (Denmark)
    • 10.5.20.1. Overview
    • 10.5.20.2. Products & services
    • 10.5.20.3. SWOT Analysis
    • 10.5.20.4. Recent Developments
    • 10.5.20.5. Strategies
    • 10.5.20.6. Financials (Based on Availability)
  • 10.5.21. FedEx Supply Chain (United States)
    • 10.5.21.1. Overview
    • 10.5.21.2. Products & services
    • 10.5.21.3. SWOT Analysis
    • 10.5.21.4. Recent Developments
    • 10.5.21.5. Strategies
    • 10.5.21.6. Financials (Based on Availability)